Rosenson, Robert S <br/><br/>
Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease.  [electronic resource] 

 -  European heart journal  Apr 2011 
 - 999-1005 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-9645 
<br/><br/><label>Standard No.: </label>10.1093/eurheartj/ehq374  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--administration & dosage<br/>Aged<br/>Apolipoproteins B--metabolism<br/>C-Reactive Protein--metabolism<br/>Cholesterol--metabolism<br/>Coronary Disease--blood<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Indoles--administration & dosage<br/>Keto Acids<br/>Male<br/>Phospholipases A2, Secretory--antagonists & inhibitors<br/>Triglycerides--metabolism